Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03245255 · ClinicalTrials.gov registry record · Phase 2
Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound
A Phase 2 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT03245255 is a Phase 2 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 80 participants.
The verdict
NCT03245255, a Phase 2 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study will use contrast echocardiography to assess the accuracy of a new non-invasive imaging method for subharmonic aided pressure estimation (SHAPE) compared to simultaneously acquired intra-cardiac pressures measured invasively during cardiac catheterization. This study is designed to verify that contrast echocardiography using the SHAPE method, already proven in a canine model and tested in a human pilot study can be used as a surrogate for cardiac catheterization with sufficient accuracy to allow clinical applicability in humans.
Interventions
- DRUG Sonazoid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-12-04 |
| Est. Completion | 2023-06-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03245255
The ClinicalTrials.gov registry entry for NCT03245255 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sonazoid is the first listed.
NCT03245255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03245255 about?
NCT03245255 is a clinical study titled "Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound". This study will use contrast echocardiography to assess the accuracy of a new non-invasive imaging method for subharmonic aided pressure estimation (SHAPE) compared to simultaneously acquired intra-cardiac pressures measured invasively during cardiac catheterization. This study is designed to verify...
What is the current status of trial NCT03245255?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2017-12-04. Estimated completion is 2023-06-07.
What interventions are being tested in trial NCT03245255?
The interventions under investigation include: Sonazoid (DRUG).
Who is sponsoring clinical trial NCT03245255?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.